These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1880157)

  • 41. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions.
    Sandset PM; Abildgaard U; Pettersen M
    Thromb Res; 1987 Aug; 47(4):389-400. PubMed ID: 3499007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor).
    Warn-Cramer BJ; Maki SL; Zivelin A; Rapaport SI
    Thromb Res; 1987 Oct; 48(1):11-22. PubMed ID: 3501173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue factor pathway inhibitor.
    Girard TJ; Broze GJ
    Methods Enzymol; 1993; 222():195-209. PubMed ID: 8412794
    [No Abstract]   [Full Text] [Related]  

  • 44. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X.
    Warr TA; Rao LV; Rapaport SI
    Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients.
    Lindahl AK; Abildgaard U; Stokke G
    Thromb Res; 1990 Aug; 59(3):651-6. PubMed ID: 2237832
    [No Abstract]   [Full Text] [Related]  

  • 46. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood.
    Abildgaard U; Lindahl AK; Sandset PM
    Haemostasis; 1991; 21(4):254-7. PubMed ID: 1794751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.
    Bajaj MS; Kuppuswamy MN; Saito H; Spitzer SG; Bajaj SP
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8869-73. PubMed ID: 2247459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of an endothelial cell product as an inhibitor of tissue factor activity.
    Colburn P; Buonassisi V
    In Vitro Cell Dev Biol; 1988 Nov; 24(11):1133-6. PubMed ID: 3192507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the tissue factor-factor VII mediated activation of coagulation factor X by a monoclonal IgM antibody expressing lupus anticoagulant activity.
    Skjønsberg OH; Wisløff F; Godal HC
    Thromb Res; 1990 May; 58(3):349-52. PubMed ID: 2112789
    [No Abstract]   [Full Text] [Related]  

  • 50. Lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Curr Stud Hematol Blood Transfus; 1991; (58):22-5. PubMed ID: 1954769
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.
    Novotny WF; Brown SG; Miletich JP; Rader DJ; Broze GJ
    Blood; 1991 Jul; 78(2):387-93. PubMed ID: 2070076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The current status of coagulation.
    Luchtman-Jones L; Broze GJ
    Ann Med; 1995 Feb; 27(1):47-52. PubMed ID: 7741998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome].
    Małyszko JS; Małyszko J; Myśliwiec M
    Pol Arch Med Wewn; 1999 Apr; 101(4):301-5. PubMed ID: 10740407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vascular function tests for diagnosis of blood coagulation disorders].
    Maruyama I
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):839-43. PubMed ID: 1919197
    [No Abstract]   [Full Text] [Related]  

  • 55. Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variables.
    Warr TA; Warn-Cramer BJ; Rao LV; Rapaport SI
    Blood; 1989 Jul; 74(1):201-6. PubMed ID: 2473796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serum thermostable and thermolabile inhibitors of tissue thromboplastin].
    Byshevskiĭ ASh; Rudzevich EL
    Vopr Med Khim; 1977; 23(4):519-25. PubMed ID: 919377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No effect of factor Xa or tissue thromboplastin and factor VII on the activation of plasminogen.
    Wiman B; Holm T; Prydz H
    Thromb Res; 1976 Nov; 9(5):523-5. PubMed ID: 136768
    [No Abstract]   [Full Text] [Related]  

  • 58. An inhibitor of factor VII from human placenta.
    Uszynski M; Godal HC
    Scand J Haematol; 1971; 8(5):392-5. PubMed ID: 5134836
    [No Abstract]   [Full Text] [Related]  

  • 59. Altered shear stress on endothelial cells leads to remodeling of extracellular matrix and induction of angiogenesis.
    Russo TA; Banuth AMM; Nader HB; Dreyfuss JL
    PLoS One; 2020; 15(11):e0241040. PubMed ID: 33211705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced inhibition of tissue factor by the extended form of an endothelial cell glycoprotein (an extrinsic pathway inhibitor).
    Colburn P; Crabb JW; Buonassisi V
    J Cell Physiol; 1991 Aug; 148(2):320-6. PubMed ID: 1880157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.